SALEM INVESTMENT COUNSELORS INC
Position in GILD — Gilead Sciences, Inc.
CIK 884423
WINSTON-SALEM, NC
Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$175,486
-$1,374 QoQ
Shares Held
1,389
+9.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,935
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. GILD ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,486 | 1,389 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $176,860 | 1,269 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $61,161 | 551 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $34,037 | 307 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $54,904 | 490 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $10,160 | 110 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $50,890 | 607 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $41,646 | 607 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $44,462 | 607 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $81,415 | 1,005 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $80,185 | 1,070 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $82,464 | 1,070 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $72,349 | 872 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $44,813 | 522 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $34,052 | 552 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $32,264 | 522 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $31,032 | 522 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $36,305 | 500 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $34,925 | 500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $34,430 | 500 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $32,315 | 500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $33,266 | 571 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $31,595 | 500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $38,470 | 500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $88,590 | 1,185 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||